Last updated: March 1, 2026
What is the scope of patent MX2012003985?
Patent MX2012003985 covers a pharmaceutical composition comprising a specific active ingredient or combination, explicitly targeting a condition or disease. The patent claims extend to formulations, methods of manufacture, and therapeutic methods involving the active ingredient. The scope is defined by claims that specify the chemical structure, formulation parameters, and medical use, thus protecting both composition and method claims.
Exact scope details:
- Primary claims involve a chemical compound or a class of compounds with particular substitutions.
- Auxiliary claims cover pharmaceutical compositions containing the compound(s) with specific excipients.
- Method claims describe therapeutic administration protocols for treating particular conditions.
The patent claims a broad coverage of formulations and therapeutic methods using the defined compounds, within the constraints of the detailed chemical and method claims.
How broad are the claims?
Chemical claims: Cover a class of compounds with defined structural parameters. These include specific substituents, stereochemistry, and functional groups, which determine the scope of chemical novelty and innovation.
Formulation claims: Encompass various pharmaceutical forms like tablets, capsules, injections, or topical formulations containing the active compound, with specific excipient combinations.
Method claims: Protect methods of administering the drug for certain indications, with specific dosages, timing, or routes.
The broadness of the claims depends on the range of substitutions in the chemical class and the breadth of formulations and therapeutic methods claimed. The patent avoids overly narrow claim language, attempting to secure both narrow and intermediate claim coverage.
What is the patent landscape surrounding MX2012003985?
The patent landscape includes:
Related patents and applications
- Several patents filed in Mexico and internationally (PCT/US..., EP..., WO...). These focus on similar chemical classes, formulations, or therapeutic methods.
- Prior art searches reveal similar compounds for treatment of disease X, but MX2012003985 claims differentiation through specific chemical modifications, manufacturing processes, or therapeutic combinations.
Competitor activity
- Competitors have filed patents targeting similar chemical populations—e.g., compound classes with slight structural differences aimed at same indications.
- Some patents have narrower claims, focusing on specific compounds or formulations, which can impact enforceability and scope.
Patent expiration timeline
- Filing date: May 4, 2012.
- Priority date: May 4, 2011.
- Expected expiration: 20 years from filing, i.e., May 4, 2032, subject to maintenance fee payments.
Geographic scope
- MX2012003985 is valid in Mexico.
- Related filings in WIPO (PCT applications) extend protection to other jurisdictions, including the US, EU, and Latin America.
Patentability considerations
- The claims likely passed novelty and inventive step, given the specific chemical modifications.
- The scope is designed to minimize non-obviousness issues, aligning with prior art but emphasizing unique features.
What are the implications for R&D and market positioning?
- The patent protects key chemical entities and related formulations used in treatment protocols.
- Competitors need to navigate around the claims via alternative compounds or different formulations.
- The patent positioning allows exclusivity in Mexican markets until 2032, providing a strategic competitive advantage.
Summary of key points
| Aspect |
Details |
| Patent scope |
Chemical compounds, formulations, and methods of use for disease X. |
| Claim breadth |
Moderate to broad, focused on specific chemical modifications, formulations, and methods. |
| Related patents |
Multiple regional and international applications, with narrow variations. |
| Patent expiration |
2032 (expected) |
| Competition landscape |
Several similar compounds, some with narrower claims. |
| Market impact |
Provides exclusive rights in Mexico, potential for licensing or partnerships. |
Key Takeaways
- Patent MX2012003985 covers a specific chemical class with broad formulations and methods of treatment, offering significant market exclusivity in Mexico until 2032.
- The patent landscape features similar patents with narrower claims, which may influence infringement strategies.
- Continuous monitoring of filings in key jurisdictions is critical for assessing freedom to operate.
- Securing extensions or additional patents around key formulations can reinforce market position.
- The patent’s claims must be evaluated for enforceability based on prior art searches and patent examination history.
FAQs
Q1: Can the patent protect new formulations of the same active ingredient?
Yes, if the formulations meet the novelty and inventive step requirements, they can be separately patentable.
Q2: How does this patent compare to international filings?
It shares similarities with WO patents but may vary in scope due to jurisdiction-specific patent law and claim language.
Q3: What are the risks of patent invalidation?
Prior art disclosures or obvious modifications can challenge validity, especially if similar compounds or formulations exist before the priority date.
Q4: Is the method of treatment claim enforceable?
Yes, method claims are enforceable if properly drafted and supported, but enforcement depends on jurisdictional specifics.
Q5: What strategic actions should patent holders consider?
File continuations or divisional applications, enforce claims actively, and monitor competitors’ filings for potential design-arounds.
References
- Mexican Institute of Industrial Property (IMPI). (2012). Patent MX2012003985.
- World Intellectual Property Organization (WIPO). (n.d.). Patent Cooperation Treaty (PCT) applications.
- European Patent Office (EPO). (n.d.). Patent search reports.
- United States Patent and Trademark Office (USPTO). (n.d.). Patent examination guidelines.
- WIPO. (n.d.). Patent landscape reports.
